MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06586515 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

630

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma
Non-small Cell Lung Cancer
Colorectal Cancer

Interventions

DRUG: LY3962673
DRUG: Cetuximab
DRUG: Gemcitabine
DRUG: nab-paclitaxel
DRUG: Oxaliplatin
DRUG: leucovorin
DRUG: Irinotecan
DRUG: 5-fluorouracil

Sponsor

Eli Lilly and Company